News

Fast-tracked skin cancer drug pembrolizumab gets approval

BBC report that a new drug for advanced skin cancer should be made available on the NHS in England, experts recommend. 

Read more: Fast-tracked skin cancer drug pembrolizumab gets approval

Rare Disease UK Publish Progress Report

UK Rare Disease Forum (the group charged with monitoring the implementation of the UK Strategy for Rare Diseases) publishes first progress report. 

Read more: Rare Disease UK Publish Progress Report

European Commission approve Odomzo (formerly LDE225)

Novartis announce approval of Odomzo (formerly LDE225).

Read more: European Commission approve Odomzo (formerly LDE225)

Alert from MHRA and British Association of Dermatologists

The Medicines and Healthcare products Regulatory Agency (MHRA) and the British Association of Dermatologists are today warning people not to purchase or use Etin Skin Solution, a lotion claiming to treat skin conditions and known to have been supplied from various Asian and African beauty shops.

Read more: Alert from MHRA and British Association of Dermatologists

Support our work

As a charitable organisation we are reliant on donations to ensure our work continues.

Read more: Support our work

Subcategories


 Originally produced by Professor P. A. Farndon, Clinical Geneticist, Jim Costello (deceased) and Margaret Costello.  We are reliant on a team of medical advisors for the clinical content of the website. We are grateful for their continuing support. 
Gorlin Syndrome Group is Registered Charity in the UK - No 1096361 
 
Checkout
Gorlin Syndrome community on HealthUnlocked
website security